Published in Nucleic Acids Res on July 01, 1974
Local mutagenesis: a method for generating viral mutants with base substitutions in preselected regions of the viral genome. Proc Natl Acad Sci U S A (1978) 8.36
Amino acid substitutions within the matrix protein of type D retroviruses affect assembly, transport and membrane association of a capsid. EMBO J (1991) 2.51
A T to A base substitution and small deletions in the conalbumin TATA box drastically decrease specific in vitro transcription. Nucleic Acids Res (1981) 2.31
Mutation causing premature termination of the polyoma virus medium T antigen blocks cell transformation. J Virol (1982) 2.11
A rapid and efficient method for region- and strand-specific mutagenesis of cloned DNA. EMBO J (1982) 1.57
Segment-specific mutagenesis: extensive mutagenesis of a lac promoter/operator element. Proc Natl Acad Sci U S A (1982) 1.33
Discovery of bisulfite-mediated cytosine conversion to uracil, the key reaction for DNA methylation analysis--a personal account. Proc Jpn Acad Ser B Phys Biol Sci (2008) 0.85
Recognition of a cytosine base lesion by a human damage-specific DNA binding protein. Nucleic Acids Res (1985) 0.81
A polymerase engineered for bisulfite sequencing. Nucleic Acids Res (2015) 0.76
A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J (1956) 124.75
Enzymatic synthesis of deoxyribonucleic acid. XXVI. Physical and chemical studies of a homogeneous deoxyribonucleic acid polymerase. J Biol Chem (1969) 10.45
Enzymatic synthesis of deoxyribonucleic acid. I. Preparation of substrates and partial purification of an enzyme from Escherichia coli. J Biol Chem (1958) 7.87
Reaction of sodium bisulfite with uracil, cytosine, and their derivatives. Biochemistry (1970) 4.05
Deamination of cytosine derivatives by bisulfite. Mechanism of the reaction. J Am Chem Soc (1974) 2.92
Enzymatic synthesis of deoxyribonucleic acid. X. Influence of bromouracil substitutions on replication. Proc Natl Acad Sci U S A (1962) 2.37
EFFECTS OF NITROUS ACID ON THE DAT COPOLYMER AS A TEMPLATE FOR DNA POLYMERASE. J Mol Biol (1964) 1.50
Role of bisulfite in the deamination and the hydrogen isotope exchange of cytidylic acid. J Am Chem Soc (1973) 1.50
The addition of sodium bisulfite to uracil and to cytosine. J Am Chem Soc (1970) 1.50
The mutagenic specificity of sodium bisulfite. Biochem Biophys Res Commun (1970) 1.48
The mutagenic action of sodium bisulfite. Biochem Biophys Res Commun (1970) 1.36
The cleavage of DNA by the oxygen-dependent reaction of bisulfite. Biochem Biophys Res Commun (1972) 1.21
Bisulfite mutagenesis in bacteriophage T4. Genetics (1971) 1.07
[Demonstration of the mutagenic action of sodium sulfite on yeast]. C R Acad Sci Hebd Seances Acad Sci D (1972) 1.06
Modification of polyuridylic acid by bisulfite: effect on double helix formation and coding properties. Biochem Biophys Res Commun (1972) 0.97
Concentration effect of bisulfite on the inactivation of transforming activity of DNA. Chem Biol Interact (1972) 0.91
Cleavage of the glycosidic linkage of pyrimidine ribonucleosides by the bisulfite-oxygen system. Nucleic Acids Res (1974) 0.82
Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A (1987) 7.38
Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci U S A (2000) 4.55
Bisulfite modification of nucleic acids and their constituents. Prog Nucleic Acid Res Mol Biol (1976) 4.36
Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res (1981) 4.30
Reaction of sodium bisulfite with uracil, cytosine, and their derivatives. Biochemistry (1970) 4.05
Reaction of bisulfite with the 5-hydroxymethyl group in pyrimidines and in phage DNAs. Biochemistry (1979) 3.91
Studies on polynucleotides. LI. Syntheses of the 64 possible ribotrinucleotides derived from the four major ribomononucleotides. J Am Chem Soc (1966) 3.83
Studies on polynucleotides, XLIX. Stimulation of the binding of aminoacyl-sRNA's to ribosomes by ribotrinucleotides and a survey of codon assignments for 20 amino acids. Proc Natl Acad Sci U S A (1965) 3.71
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene (1999) 3.32
A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc Natl Acad Sci U S A (1999) 3.26
Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci U S A (1986) 2.99
Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res (1982) 2.82
Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res (1988) 2.35
In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients. Eur J Nucl Med (1997) 2.15
Involvement of 14-3-3 proteins in nuclear localization of telomerase. EMBO J (2000) 2.05
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer (2009) 2.05
Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J Histochem Cytochem (1989) 1.89
Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. Biochem Pharmacol (1985) 1.86
Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res (1989) 1.85
Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance. 170- to 180-kilodalton membrane glycoprotein is an ATPase. J Biol Chem (1988) 1.85
Potentiation of vincristine and Adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors. Cancer Res (1983) 1.84
Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood (1992) 1.80
ASK1 mediates apoptotic cell death induced by genotoxic stress. Oncogene (1999) 1.70
Rhizoxin, a macrocyclic lactone antibiotic, as a new antitumor agent against human and murine tumor cells and their vincristine-resistant sublines. Cancer Res (1986) 1.68
A DNA-topoisomerase-II-binding protein with eight repeating regions similar to DNA-repair enzymes and to a cell-cycle regulator. Eur J Biochem (1997) 1.65
Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells. Cancer Res (1984) 1.64
Isolation of paralysis-inducing murine leukemia viruses from Friend virus passaged in rats. J Virol (1984) 1.59
Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene (1999) 1.58
A human IAP-family gene, apollon, expressed in human brain cancer cells. Biochem Biophys Res Commun (1999) 1.56
G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3' telomeric overhang in cancer cells. Oncogene (2006) 1.53
Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia. Oncogene (2001) 1.53
Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer (1993) 1.52
Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases. Oncogene (1998) 1.51
Characterization of dihydropyrimidine dehydrogenase on immunohistochemistry in colon carcinoma, and correlation between immunohistochemical score and protein level or messenger RNA expression. Ann Oncol (2000) 1.50
ATP-binding properties of P glycoprotein from multidrug-resistant KB cells. FASEB J (1987) 1.50
Role of bisulfite in the deamination and the hydrogen isotope exchange of cytidylic acid. J Am Chem Soc (1973) 1.50
The addition of sodium bisulfite to uracil and to cytosine. J Am Chem Soc (1970) 1.50
Conserved BRCT regions of TopBP1 and of the tumor suppressor BRCA1 bind strand breaks and termini of DNA. Oncogene (1999) 1.45
Promotion by verapamil of vincristine responsiveness in tumor cell lines inherently resistant to the drug. Cancer Res (1983) 1.43
An intraoperative fluorescent imaging system in organ transplantation. Transplant Proc (2004) 1.40
Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers. Cancer Res (1983) 1.39
Functional involvement of P-glycoprotein in blood-brain barrier. J Biol Chem (1992) 1.39
Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells. Cell Immunol (1996) 1.38
Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel. Cancer Res (1999) 1.37
The mutagenic action of sodium bisulfite. Biochem Biophys Res Commun (1970) 1.36
P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity. Proc Natl Acad Sci U S A (1997) 1.36
Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur J Biochem (1996) 1.34
5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins. Br J Cancer (1998) 1.32
Specificity of sRNA for recognition of codons as studied by the ribosomal binding technique. J Mol Biol (1966) 1.31
Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer. Br J Cancer (2000) 1.31
Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. J Biol Chem (1993) 1.30
Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochem Biophys Res Commun (1995) 1.28
The permanganate oxidation of thymine. Biochim Biophys Acta (1970) 1.28
Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis. Blood (2000) 1.27
Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res (1989) 1.26
Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones. Jpn J Cancer Res (1986) 1.26
Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Br J Cancer (1999) 1.25
Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer. Cancer Res (1996) 1.25
Adenovirus deoxyribonucleic acid replication. Characterization of the enzyme activities of a soluble replication system. J Biol Chem (1977) 1.24
Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody. Cancer Res (1990) 1.23
NH2-terminal BH4 domain of Bcl-2 is functional for heterodimerization with Bax and inhibition of apoptosis. J Biol Chem (1999) 1.23
Requirement of expression of P-glycoprotein on human natural killer leukemia cells for cell-mediated cytotoxicity. Biochem Pharmacol (1998) 1.22
Avulsion of the hamstring muscles from the ischial tuberosity. A report of two cases. Clin Orthop Relat Res (1988) 1.22
Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res (1988) 1.22
Reaction of cytidine with semicarbazide in the presence of bisulfite. A rapid modification specific for single-stranded polynucleotide. Biochemistry (1976) 1.22
A monoclonal antibody-Pseudomonas toxin conjugate that specifically kills multidrug-resistant cells. Proc Natl Acad Sci U S A (1987) 1.21
The cleavage of DNA by the oxygen-dependent reaction of bisulfite. Biochem Biophys Res Commun (1972) 1.21
Aspartate-based inhibitor of interleukin-1 beta-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 cells. Biochem Biophys Res Commun (1995) 1.21
c-Jun NH2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis. J Biol Chem (1997) 1.19
Actin cleavage by CPP-32/apopain during the development of apoptosis. Oncogene (1997) 1.19
N4-aminocytidine, a nucleoside analog that has an exceptionally high mutagenic activity. Nucleic Acids Res (1983) 1.19
Serum and plasma M(r) 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma. Cancer Res (1993) 1.19
Diagnosis and sero-epizootiology of equine herpesvirus type 1 and type 4 infections in Japan using a type-specific ELISA. J Vet Med Sci (1998) 1.17
Isolation and characterization of Desulfitobacterium sp. strain Y51 capable of efficient dehalogenation of tetrachloroethene and polychloroethanes. Biosci Biotechnol Biochem (2001) 1.16
Elevated expression of DNA topoisomerase II in camptothecin-resistant human tumor cell lines. Cancer Res (1990) 1.16
Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein (MRP) in human gastric cancer cells. Biochem Biophys Res Commun (1999) 1.15
P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies. Br J Cancer (1990) 1.15
Cleavage and inactivation of antiapoptotic Akt/PKB by caspases during apoptosis. J Cell Physiol (2000) 1.15
MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines. J Natl Cancer Inst (1994) 1.15
Caspase-mediated cleavage of cytoskeletal actin plays a positive role in the process of morphological apoptosis. Oncogene (1999) 1.15
Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins. Biochem Biophys Res Commun (1998) 1.15
Mouse strain resistant to N-, B-, and NB-tropic murine leukemia viruses. J Virol (1976) 1.15
Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity. Cancer Res (2001) 1.13
Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR - ABL tyrosine kinase, CGP 57148. Cell Death Differ (1998) 1.12
Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials. Cancer Res (1996) 1.12
Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13. Clin Exp Metastasis (1995) 1.12
P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells. Life Sci (1992) 1.12
Immunocytochemical localization of P170 at the plasma membrane of multidrug-resistant human cells. J Histochem Cytochem (1987) 1.11
Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients. Dis Colon Rectum (1998) 1.11
Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions. Oncogene (2008) 1.11
HAM1, the gene controlling 6-N-hydroxylaminopurine sensitivity and mutagenesis in the yeast Saccharomyces cerevisiae. Yeast (1996) 1.10
Reaction of sodium hypochlorite with nucleic acids and their constituents. Chem Pharm Bull (Tokyo) (1971) 1.10
Prevention of phosphatidylinositol 3'-kinase-Akt survival signaling pathway during topotecan-induced apoptosis. Cancer Res (2000) 1.10
Transfection with protein kinase C alpha confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Commun (1991) 1.10
The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier. Brain Res (2000) 1.09
Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis. J Cell Physiol (2001) 1.09
Apoxin I, a novel apoptosis-inducing factor with L-amino acid oxidase activity purified from Western diamondback rattlesnake venom. J Biol Chem (1997) 1.09
Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl) cytosine) and its N4-palmitoyl derivative (CS-682). Int J Cancer (1999) 1.07